XML 25 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Oct. 31, 2015
Oct. 31, 2014
Oct. 31, 2013
Revenues:      
Product sales (including $100.5 million, $115.0 million and $81.6 million of related party revenue) $ 128,595 $ 136,842 $ 145,071
Service agreements and license revenues (including $11.4 million, $14.9 million and $20.1 million of related party revenue) 21,012 25,956 28,141
Advanced technologies contract revenues (including $0.6 million, $0.4 million and $0.3 million of related party revenue) 13,470 17,495 14,446
Total revenues 163,077 180,293 187,658
Costs of revenues:      
Cost of product sales 118,530 126,866 136,989
Cost of Services 18,301 23,037 29,683
Cost of advanced technologies contract revenues 13,470 16,664 13,864
Total costs of revenues 150,301 166,567 180,536
Gross profit 12,776 13,726 7,122
Operating expenses:      
Administrative and selling expenses 24,226 22,797 21,218
Research and development expenses 17,442 18,240 15,717
Total operating expenses 41,668 41,037 36,935
Loss from operations (28,892) (27,311) (29,813)
Interest expense (2,960) (3,561) (3,973)
Income from equity investment 0 0 46
Other income (expense), net 2,442 (7,523) (1,208)
Loss before provision for income taxes (29,410) (38,395) (34,948)
Provision for income taxes (274) (488) (371)
Net loss (29,684) (38,883) (35,319)
Net loss attributable to noncontrolling interest 325 758 961
Net loss attributable to FuelCell Energy, Inc. (29,359) (38,125) (34,358)
Preferred stock dividends (3,200) (3,200) (3,200)
Net loss to common shareholders $ (32,559) $ (41,325) $ (37,558)
Net loss to common shareholders per share      
Basic $ (1.33) $ (2.02) $ (2.42)
Diluted $ (1.33) $ (2.02) $ (2.42) [1]
Weighted average shares outstanding      
Basic 24,513,731 20,473,915 15,543,750
Diluted 24,513,731 20,473,915 15,543,750
[1] Due to the net loss to common shareholders in each of the years presented above, diluted earnings per share was computed without consideration to potentially dilutive instruments as their inclusion would have been antidilutive. Potentially dilutive instruments include stock options, warrants, unvested RSAs and RSUs and convertible preferred stock. At October 31, 2015, 2014 and 2013, there were options to purchase 0.3 million shares of common stock. At October 31, 2015, 2014 and 2013, respectively, there were warrants to purchase 0.2 million, 0.5 million and 0.4 million shares of common stock, which were not included in the calculation of diluted earnings per share as they would be antidiulutive.